Related Experiment Video
Updated: Aug 11, 2026
Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
How Prosorba apheresis came to be used for rheumatoid arthritis: a personal historical perspective
1Cedars-Sinai/UCLA Medical Center, Los Angeles, California, USA. dwallace@ucla.edu
Abstract:
The Prosorba column is an effective treatment for refractory rheumatoid arthritis. In this article, I review how membrane methodologies evolved with regard to the management of the disorder through a focused review of rarely cited key references and personal experience.
Insights
The Prosorba column effectively treats refractory rheumatoid arthritis. This review explores the evolution of membrane technologies in managing this autoimmune disorder, drawing on key references and experience.
Area of Science:
- Immunology
- Biomedical Engineering
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease causing joint inflammation and damage.
- Refractory RA cases present significant treatment challenges, necessitating advanced therapeutic strategies.
Observation:
- The Prosorba column, a membrane-based therapy, has demonstrated efficacy in managing refractory rheumatoid arthritis.
- Evolution of membrane technologies has significantly impacted the treatment landscape for RA.
Findings:
- Review of rarely cited references and personal experience highlights the Prosorba column's effectiveness.
- Membrane methodologies have advanced, offering improved management options for rheumatoid arthritis.
Implications:
- The Prosorba column represents a valuable therapeutic option for patients with refractory rheumatoid arthritis.
- Continued innovation in membrane technology may lead to further improvements in RA management.
